|
US6142163A
(en)
*
|
1996-03-29 |
2000-11-07 |
Lam Research Corporation |
Method and apparatus for pressure control in vacuum processors
|
|
ATE504572T1
(de)
*
|
1999-09-02 |
2011-04-15 |
Shionogi & Co |
Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
|
|
DK1231910T3
(da)
*
|
1999-11-16 |
2009-08-31 |
Oncozyme Pharma Inc |
Pentamidin til behandling af cancer
|
|
US7115665B1
(en)
|
2000-11-16 |
2006-10-03 |
Onocozyme Pharma, Inc. |
Inhibitors of endo-exonuclease activity for treating cancer
|
|
US6242461B1
(en)
*
|
2000-01-25 |
2001-06-05 |
Pfizer Inc. |
Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
|
|
WO2001095905A1
(fr)
*
|
2000-06-14 |
2001-12-20 |
Shionogi & Co., Ltd. |
Inhibiteur d'enzymes possedant deux ions metal divalents en tant que centres actifs
|
|
WO2002002516A2
(en)
*
|
2000-06-30 |
2002-01-10 |
Thomas Jefferson University |
Inhibitors of hiv integrase
|
|
US20020124843A1
(en)
*
|
2001-02-01 |
2002-09-12 |
Skiba Jeffry B. |
Eye medication delivery system
|
|
WO2002083126A1
(en)
|
2001-04-11 |
2002-10-24 |
Idenix (Cayman) Limited |
Phenylindoles for the treatment of hiv
|
|
US6958211B2
(en)
*
|
2001-08-08 |
2005-10-25 |
Tibotech Bvba |
Methods of assessing HIV integrase inhibitor therapy
|
|
IL160208A0
(en)
*
|
2001-08-31 |
2004-07-25 |
Neurochem Int Ltd |
Amidine derivatives for treating amyloidosis
|
|
AU2003258145A1
(en)
*
|
2002-08-07 |
2004-02-25 |
Idenix (Cayman) Limited |
Substituted phenylindoles for the treatment of hiv
|
|
DE602004021211D1
(de)
*
|
2003-03-07 |
2009-07-09 |
Merck Patent Gmbh |
Fluorene und Arylgruppen enthaltende Mono-, Oligo- und Polymere
|
|
US7262223B2
(en)
*
|
2004-01-23 |
2007-08-28 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
|
EP1742936A2
(en)
*
|
2004-04-13 |
2007-01-17 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
DE602005011031D1
(en)
|
2004-09-17 |
2008-12-24 |
Idenix Pharmaceuticals Inc |
Phosphoindole als hiv-inhibitoren
|
|
KR20090077813A
(ko)
|
2006-09-29 |
2009-07-15 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌
|
|
CA2740193A1
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2367823A1
(en)
|
2008-12-23 |
2011-09-28 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2393359A4
(en)
*
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
COMPOUND DIBENZIMIDAZOLE DERIVATIVES
|
|
US8314135B2
(en)
*
|
2009-02-09 |
2012-11-20 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole antivirals
|
|
US8188132B2
(en)
*
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8242156B2
(en)
*
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8101643B2
(en)
*
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
CN102459165B
(zh)
*
|
2009-04-15 |
2015-09-02 |
Abbvie公司 |
抗病毒化合物
|
|
WO2010132538A1
(en)
*
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
CA2763140A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
US8772505B2
(en)
|
2009-05-29 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
|
UA118080C2
(uk)
*
|
2009-06-11 |
2018-11-26 |
Еббві Айрленд Анлімітед Компані |
Противірусні сполуки
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2010148006A1
(en)
*
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
*
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
*
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
*
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
*
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011031904A1
(en)
*
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8653070B2
(en)
*
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
MA34013B1
(fr)
|
2010-01-25 |
2013-02-01 |
Enanta Pharm Inc |
Inhibiteurs du virus de l'hépatite c
|
|
US8623814B2
(en)
*
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8178531B2
(en)
*
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
KR20120124495A
(ko)
*
|
2010-03-04 |
2012-11-13 |
이난타 파마슈티칼스, 인코포레이티드 |
Ｈｃｖ 복제의 억제제로서의 조합 제약 작용제
|
|
EA201290882A1
(ru)
*
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
|
EP2555622A4
(en)
|
2010-04-09 |
2013-09-18 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
EP2575819A4
(en)
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
EP2603080A4
(en)
|
2010-08-12 |
2014-01-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
WO2012158861A2
(en)
|
2011-05-18 |
2012-11-22 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
|
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
|
EP3434670B1
(en)
*
|
2012-04-13 |
2021-09-01 |
LG Chem, Ltd. |
Novel nitrogen-containing heterocyclic compound and organic electronic device using same
|
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
|
EP3089757A1
(en)
|
2014-01-03 |
2016-11-09 |
AbbVie Inc. |
Solid antiviral dosage forms
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017223260A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Albert Einstein College Of Medicine, Inc. |
Pu.1 inhibitors
|
|
CN109553608B
(zh)
*
|
2017-09-26 |
2020-12-08 |
北京大学 |
一类五元六元杂环化合物及其制备方法和治疗肿瘤的用途
|
|
CN113264925A
(zh)
*
|
2020-02-14 |
2021-08-17 |
上海美悦生物科技发展有限公司 |
一种杂环化合物及其制备方法和用途
|